Compare MGTX & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | ELVR |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2018 | 2018 |
| Metric | MGTX | ELVR |
|---|---|---|
| Price | $10.96 | $41.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.57 | N/A |
| AVG Volume (30 Days) | ★ 824.2K | 32.3K |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.02 | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $81,391,000.00 | N/A |
| Revenue This Year | $141.38 | $90.73 |
| Revenue Next Year | N/A | $42.59 |
| P/E Ratio | $8.50 | ★ N/A |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $6.62 | $22.27 |
| 52 Week High | $15.35 | $102.80 |
| Indicator | MGTX | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 26.47 | 22.75 |
| Support Level | $8.84 | $41.10 |
| Resistance Level | $11.85 | $69.04 |
| Average True Range (ATR) | 0.56 | 1.73 |
| MACD | -0.28 | -0.74 |
| Stochastic Oscillator | 9.42 | 1.61 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is lithium mining and processing at North American Lithium(NAL) and ongoing identification, evaluation and development of its world-wide portfolio of mineral exploration assets, predominantly focusing on lithium. Its segments are North American Lithium, and All other operations. Majority of revenue comes from North American Lithium. It has presence in China, and USA. Majority of revenue comes from China.